Prescriptions for estrogen replacement therapy in Ontario before and after publication of the Women's Health Initiative Study

Comment

Peter C Austin et al. JAMA. 2003.

. 2003 Jun 25;289(24):3241-2.

doi: 10.1001/jama.289.24.3241.

No abstract available

Comment on

Randomized trial of estrogen plus progestin for secondary prevention of coronary heart disease in postmenopausal women. Heart and Estrogen/progestin Replacement Study (HERS) Research Group.
Hulley S, Grady D, Bush T, Furberg C, Herrington D, Riggs B, Vittinghoff E. Hulley S, et al. JAMA. 1998 Aug 19;280(7):605-13. doi: 10.1001/jama.280.7.605. JAMA. 1998. PMID: 9718051 Clinical Trial.
Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results From the Women's Health Initiative randomized controlled trial.
Rossouw JE, Anderson GL, Prentice RL, LaCroix AZ, Kooperberg C, Stefanick ML, Jackson RD, Beresford SA, Howard BV, Johnson KC, Kotchen JM, Ockene J; Writing Group for the Women's Health Initiative Investigators. Rossouw JE, et al. JAMA. 2002 Jul 17;288(3):321-33. doi: 10.1001/jama.288.3.321. JAMA. 2002. PMID: 12117397 Clinical Trial.